Inulin And Sodium Chloride is one of 73 small molecule programs targeting Cystic Fibrosis. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
FDA Application
NDA/BLA/ANDA regulatory filings
Pipeline
Competition
105 competitors in Cystic Fibrosis
Inulin And Sodium Chloride
Ibsrela
Zyvox
Avelox
HSK31858
Myambutol
Tygacil
ELX/TEZ/IVA
Trikafta
VNZ/TEZ/D-IVA
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Regulatory
Jan 1, 1982
INULIN AND SODIUM CHLORIDE
NDA NDA002282
Sources
Details